The Valley Desk

NCT01676831 · Interventional trial

Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL)

Overall registry status Completed

Phase 1 · Phase 2

Conditions Cutaneous T Cell Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov